Blood alterations preceding clinical manifestation of glioblastoma.

被引:0
|
作者
Ilhan-Mutlu, Aysegul
Wagner, Ludwig
Woehrer, Adelheid
Susanne, Jungwirth
Marosi, Christine
Fischer, Peter
Preusser, Matthias
机构
[1] Med Univ Vienna, Vienna, Austria
[2] Danube Hosp, Dept Psychiat, Vienna, Austria
[3] Med Univ Vienna, Inst Neurol, Vienna, Austria
[4] Med Univ Vienna, Ctr Comprehens Canc, CNS Tumours Unit, Vienna, Austria
[5] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[6] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2024
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma.
    Weller, Michael
    Sill, Martin
    Hentschel, Bettina
    Felsberg, Joerg
    Jones, David T. W.
    Gramatzki, Dorothee
    Kaulich, Kerstin
    Happold, Caroline
    Tonn, Joerg
    Herrlinger, Ulrich
    Schackert, Gabriele
    Westphal, Manfred
    Capper, David
    Kumar, Rajiv
    Hemminki, Kari
    Pietsch, Torsten
    Loeffler, Markus
    Pfister, Stefan M.
    von Deimling, Andreas
    Reifenberger, Guido
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Outcomes after hospitalization in patients with recurrent glioblastoma.
    Coecho Barata, Pedro Miguel
    Kamiya-Matsuoka, Carlos
    Lee-Kim, Soo
    Loghin, Monica Elena
    O'Brien, Barbara Jane
    Tremont-Lukats, Ivo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.
    Neyns, Bart
    Ben Salama, Laila
    Awada, Gil
    De Cremer, Jennifer
    Schwarze, Julia Katharina
    Seynaeve, Laura
    Du Four, Stephanie
    Fischbuch, Lydia
    Vanbinst, Anne-Marie
    Everaert, Hendrik
    Michotte, Alex
    Rogiers, Anne
    Theuns, Peter
    Duerinck, Johnny
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Phase II trial of dovitinib in recurrent glioblastoma.
    Ahluwalia, Manmeet Singh
    Papadantonakis, Nikolaos
    Venur, Vyshak Alva
    Schilero, Cathy
    Peereboom, David M.
    Stevens, Glen
    Rosenfeld, Steven
    Vogelbaum, Michael A.
    Elson, Paul
    Nixon, Andrew B.
    McCrae, Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Phase 2 study of aldoxorubicin in relapsed glioblastoma.
    Groves, Morris D.
    Portnow, Jana
    Boulmay, Brian C.
    Chawla, Sant P.
    Dinh, Hillary
    Chawla, Shanta
    Wieland, Scott
    Levitt, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Age as a prognostic factor for treatment outcomes in glioblastoma.
    Braun, Kelly
    Mohapatra, Suryanarayan
    Choi, April
    Ahluwalia, Manmeet
    Jia, Xuefei
    NEUROLOGY, 2017, 88
  • [47] Albumin levels and Prognostic Nutritional Index in glioblastoma.
    Bamashmos, Anas Saeed
    Barnett, Addison
    Ali, Assad
    Li, Honq
    Angelov, Lilyana
    Barnett, Gene H.
    Mohammadi, Alireza Mohammad
    Chao, Samuel T.
    Yu, Jennifer S.
    Murphy, Erin Sennett
    Suh, John H.
    Stevens, Glen
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    Wei, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Demographic disparities influencing survival of patients with glioblastoma.
    Ayoobkhan, Fathima Shehnaz
    Ganiyani, Mohammad Arfat
    Pustake, Manas
    Ahmad, Shahzaib
    Podder, Vivek
    Bellur, Shreyas S.
    Howal, Prashant
    Shah, Aditya
    Goodman, Judie R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Early palliative care interventions in patients with glioblastoma.
    Ambady, Prakash
    Hambelton, Connor
    Fu, Rongwei
    Firkins, Jenny
    Neuwelt, Edward A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Comparison of Two oHSV Vectors for the Treatment of Glioblastoma.
    Jackson, Joseph W.
    Hall, Bonnie L.
    Bailey, Lisa
    Queva, Christophe
    Chiocca, E. Antonio
    Cohen, Justus B.
    Glorioso, Joseph C.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)